NEW YORK (GenomeWeb News) – Sequenom today lowered its revenue forecast for 2008 by 5 percent compared to earlier forecasts, citing softer than expected sales in the US market for its first quarter.
 
The San Diego-based firm revised its 2008 guidance downward to a range between $50 million and $53 million from previous guidance of between $53 million and $56 million. Its expected net loss, however, remained unchanged from previous estimates of $30 million to $33 million for the year.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.